Current and novel device-led approaches for targeted obstructive sleep apnoea screening, diagnosis, treatment, and long-term management

Novel OSA-related devices are enhancing clinical practice by improving access, adherence, and therapy outcomes. Patients and clinicians are encouraged to embrace the technology with caution. Challenges remain in the accuracy of diagnostic and treatment devices, ensuring data privacy, and integrating these tools into clinical practice. Regulatory bodies must urge for independent clinical trial validation standards, algorithmic transparency, and education on novel devices for patients and clinicians, to ensure safe implementation. With continued innovation, validation, and adoption, device-led care may become central to the proactive and patient-centered future of OSA management.